Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Non-equilibrium in the Cell01:16

Non-equilibrium in the Cell

5.3K
An important concept in studying metabolism and energy is that of chemical equilibrium. Most chemical reactions are reversible. They can proceed in both directions, releasing energy into their environment in one direction, and absorbing it from the environment in the other direction. The same is true for the chemical reactions involved in cell metabolism, such as the breaking down and building up of proteins into and from individual amino acids, respectively. Reactants within a closed system...
5.3K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Modular Deep Learning for Direct RNA Sequence Design via Self-Contained RNA Units.

bioRxiv : the preprint server for biology·2026
Same author

A diffusion-based framework for designing molecules in flexible protein pockets.

Science advances·2026
Same author

ChironRNA: Steric Clashes Resolution in RNA Structures via E(3)-Equivariant Diffusion.

bioRxiv : the preprint server for biology·2026
Same author

Unified protein-small molecule graph neural networks for binding site prediction.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

ATLAS: Graph-based 3D RNA Motif Library Incorporating non-Watson-Crick Interactions.

bioRxiv : the preprint server for biology·2026
Same author

Multimodal Bond Reconstruction toward Generative Molecular Design.

Journal of chemical information and modeling·2026
Same journal

A one-step immunoassay of Tau protein based on flow cytometric counting of target-induced nanoaggregates.

Chemical communications (Cambridge, England)·2026
Same journal

Decarboxylative alkylation of unactivated olefins <i>via</i> photoinduced Fe-LMCT: access to alkylated dihydropyrazoles/tetrahydropyridazines.

Chemical communications (Cambridge, England)·2026
Same journal

MOF-ionic liquid engineered polymer electrolyte for advanced solid-state sodium metal batteries.

Chemical communications (Cambridge, England)·2026
Same journal

Chemically-fueled transient peptide hydrogel enabling programmable time-gated functions.

Chemical communications (Cambridge, England)·2026
Same journal

The first structurally characterized coordination compounds with homocysteine.

Chemical communications (Cambridge, England)·2026
Same journal

Bimetallic Bi-In interfaces on micropyramidal silicon for efficient solar-driven CO<sub>2</sub>-to-formate conversion.

Chemical communications (Cambridge, England)·2026
查看所有相关文章

相关实验视频

Updated: Jan 9, 2026

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.5K

基于的药物设计使用生成性AI.

Srinivasan Ekambaram1, Nikolay V Dokholyan1,2

  • 1Department of Neurology, University of Virginia, Charlottesville, VA 22901, USA. dokh@virginia.edu.

Chemical communications (Cambridge, England)
|December 11, 2025
PubMed
概括
此摘要是机器生成的。

人工智能 (AI) 正在通过实现生成设计和相互作用建模来彻底改变类药物发现. 化工和人工智能的进步加速了有针对性的治疗方法的开发,提高了生物可用性和缩短了时间表.

更多相关视频

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library
13:37

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

18.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.5K

相关实验视频

Last Updated: Jan 9, 2026

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.5K
Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library
13:37

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

18.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.5K

科学领域:

  • 药物发现和开发 药物发现和开发
  • 计算化学计算化学
  • 生物技术是生物技术.

背景情况:

  • 类治疗药物具有高特异性和可调的药理动力学.
  • 人工智能 (AI) 通过结构预测和生成建模加速类药物设计.
  • 在预测序列属性,如溶解性和免疫性等方面仍然存在挑战.

研究的目的:

  • 审查人工智能驱动的基药物设计的最新进展.
  • 检查人工智能在生成架构,交互建模,选和交付中的应用.
  • 讨论AI加速发现的局限性和未来方向.

主要方法:

  • 对新序列生成的深度学习架构 (GNNs,变压器,扩散模型) 的审查.
  • 探索化学创新 (循环化,接,非正规氨基酸,纳米粒子) 以提高生物可用性.
  • 对人工智能驱动的选和自主合成进行分析,以加快发现时间表.

主要成果:

  • 人工智能显著加速了新序列的设计和发现.
  • 化學的創新提高了生物可用性和透性,克服了傳輸方面的挑戰.
  • 发现时间从几年缩短到几个月,批准的类药物数量越来越多.

结论:

  • 人工智能,特别是深度学习,是疗法开发中的变革力量.
  • 整合人工智能与先进的化学和自主合成是未来药物发现的关键.
  • 解决数据质量和实际挑战对于实现自主药物发现的全部潜力至关重要.